Literature DB >> 19234649

Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Haluk R Unalp1, Hayrullah Derici, Erdinc Kamer, Ali D Bozdag, Ercument Tarcan, Mehmet A Onal.   

Abstract

BACKGROUND: We sought to review the clinical presentation and outcomes of surgical management of gastrointestinal stromal tumours (GISTs).
METHODS: We reviewed clinical and pathological records of 41 patients (23 men and 18 women) with GISTs. We performed survival analyses using the Kaplan- Meier method and evaluated long-term survival and the independent prognostic factors that affect survival using univariate analyses. We used the Cox proportional hazards regression model to estimate the simultaneous effect on overall survival.
RESULTS: The stomach was the most common tissue of origin (n = 20, 48.8%). The mean tumour diameter was 8.3 cm. We detected advanced-stage tumours in 22 (53.7%) patients. We performed complete resection in 31 (75.6%) patients. Mitotic count was greater than 5/50 high-power field [HPF] in 22 (53.6%) patients. Immunohistochemical staining for CD117 was positive in 40 (97.6%) patients. Five patients (12.2%) died in the early postoperative period. The mean follow-up period was 38.7 months. The median length of survival was 53 months and the 5-year survival rate was 49.4%. Univariate analyses revealed significantly enhanced survival for the following variables: patient age less than 60 years (p = 0.011), male sex (p = 0.048), tumour diameter less than 5 cm (p = 0.029), low-risk tumour according to Fletcher classification (p = 0.022), complete resection (p < 0.001), and lack of local recurrence (p < 0.001) and/or metastasis (p < 0.001). Our Cox proportional hazards model revealed that complete tumour resection was the only factor to increase survival.
CONCLUSION: Overall survival is significantly affected by positive margins. A complete surgical resection with negative margins is the best method for definitive treatment of GISTs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234649      PMCID: PMC2637642     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  44 in total

1.  Leiomyosarcoma: not all gastric malignancies have a dismal prognosis.

Authors:  T A Miller
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

Review 2.  Gastrointestinal stromal tumors: biology and treatment.

Authors:  Florence Duffaud; Jean-Yves Blay
Journal:  Oncology       Date:  2003       Impact factor: 2.935

Review 3.  Management of gastrointestinal stromal tumors: from diagnosis to treatment.

Authors:  Pascal Bucher; Peter Villiger; Jean-François Egger; Leo H Buhler; Philippe Morel
Journal:  Swiss Med Wkly       Date:  2004-03-20       Impact factor: 2.193

4.  Gastrointestinal sarcomas. Analysis of prognostic factors.

Authors:  P C McGrath; J P Neifeld; W Lawrence; S Kay; J S Horsley; G A Parker
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

5.  Gastrointestinal stromal tumor. Correlation of computed tomography findings with tumor grade and mortality.

Authors:  Ukihide Tateishi; Tadashi Hasegawa; Mitsuo Satake; Noriyuki Moriyama
Journal:  J Comput Assist Tomogr       Date:  2003 Sep-Oct       Impact factor: 1.826

6.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

7.  Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging.

Authors:  E H Ng; R E Pollock; M F Munsell; E N Atkinson; M M Romsdahl
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

8.  Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era.

Authors:  Peter C Wu; Alex Langerman; Christopher W Ryan; John Hart; Susan Swiger; Mitchell C Posner
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

9.  Myosarcomas of the stomach: natural history, prognostic factors and management.

Authors:  M H Shiu; G H Farr; D N Papachristou; S I Hajdu
Journal:  Cancer       Date:  1982-01-01       Impact factor: 6.860

10.  Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST).

Authors:  I Besana-Ciani; L Boni; G Dionigi; A Benevento; R Dionigi
Journal:  Scand J Surg       Date:  2003       Impact factor: 2.360

View more
  11 in total

1.  Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.

Authors:  Martin D McCarter; Cristina R Antonescu; Karla V Ballman; Robert G Maki; Peter W T Pisters; George D Demetri; Charles D Blanke; Margaret von Mehren; Murray F Brennan; Linda McCall; David M Ota; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2012-07       Impact factor: 6.113

2.  The predictive value of preoperative 18F-fluorodeoxyglucose PET for postoperative recurrence in patients with localized primary gastrointestinal stromal tumour.

Authors:  Kanae Kawai Miyake; Yuji Nakamoto; Yoshiki Mikami; Shiro Tanaka; Tatsuya Higashi; Eiji Tadamura; Tsuneo Saga; Shunsuke Minami; Kaori Togashi
Journal:  Eur Radiol       Date:  2016-02-06       Impact factor: 5.315

3.  Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.

Authors:  Yan Zhu; Mei-Dong Xu; Chen Xu; Xiao-Cen Zhang; Shi-Yao Chen; Yun-Shi Zhong; Yi-Qun Zhang; Wei-Feng Chen; Tian-Yin Chen; Jia-Xin Xu; Li-Qing Yao; Quan-Lin Li; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

4.  Prognostic factors for primary gastrointestinal stromal tumours: are they the same in the multidisciplinary treatment era?

Authors:  Ferdinando C M Cananzi; Bruno Lorenzi; Ajay Belgaumkar; Charlotte Benson; Ian Judson; Satvinder Mudan
Journal:  Langenbecks Arch Surg       Date:  2014-01-12       Impact factor: 3.445

5.  Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour.

Authors:  Cuiping Zhou; Xiaohui Duan; Xiang Zhang; Huijun Hu; Dongye Wang; Jun Shen
Journal:  Eur Radiol       Date:  2015-12-23       Impact factor: 5.315

6.  Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.

Authors:  Jiehua Li; Haitian Zhang; Zhibai Chen; Ka Su
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

7.  Small EUS-suspected gastrointestinal stromal tumors of the stomach: An overview for the current state of management.

Authors:  Ender Gunes Yegin; Deniz Guney Duman
Journal:  Endosc Ultrasound       Date:  2016 Mar-Apr       Impact factor: 5.628

Review 8.  Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis.

Authors:  Xiaofei Zhi; Baofei Jiang; Junbo Yu; Oluf Dimitri Røe; Jun Qin; Qingfeng Ni; Luning Sun; Meirong Xu; Jianwei Zhu; Lilin Ma
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

9.  Twin pregnancy complicated by an adnexal mass.

Authors:  Sean D Coveney
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

10.  A Retrospective Study of Postoperative Outcomes in 98 Patients Diagnosed with Gastrointestinal Stromal Tumor (GIST) of the Upper, Middle, and Lower Gastrointestinal Tract Between 2009 and 2019 at a Single Center in Poland.

Authors:  Patryk Zemła; Anna Stelmach; Beata Jabłońska; Dariusz Gołka; Sławomir Mrowiec
Journal:  Med Sci Monit       Date:  2021-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.